Contract Research
Redbud raises $10M in series A round as CRO focusing on science-driven clinical development
Redbud Medicine is a next-generation clinical CRO focusing on science-based clinical development services. The company offers full-service development from...
September 13, 2022 | News
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility
WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing faci...
September 12, 2022 | News
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData...
September 05, 2022 | News
Viva Biotech Announced 2022 Interim Results
Financial Highlights for the 6 months ended June 30, 2022: Revenue amounted to RMB1,108.7 million, representing a year-on-year ("YoY") increas...
August 30, 2022 | News
Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea
SK bioscience and GSK recently announced the successful authorization:SK bioscience announced that 'SKYCovione(TM),' South Korea's first COVID-19 vaccine c...
July 14, 2022 | News
Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development
Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it...
May 20, 2022 | News
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
The Summit will feature insights from leading Novotech experts tapping decades of oncology clinical experience in the APAC region. They include:- Dr. Raman...
May 12, 2022 | News
Novotech Acquires US CRO NCGS, Expands Global Expertise
Novotech CEO Dr. John Moller said "We are very pleased to acquire such an impressive company with a strong history of quality and delivery in the United St...
May 05, 2022 | News
Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza
Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digita...
April 14, 2022 | News
National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development
The project initialized by National Cancer Center Research Institute. Under the agreement, National Cancer Center and GenScript Biotech will collaborate on...
February 07, 2022 | News
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive ...
January 18, 2022 | News
Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA
Merck, a leading science and technology company, has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufac...
January 07, 2022 | News
NovAliX acquires Sanofi site in Strasbourg and creates Guy Ourisson Research Campus
NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces the first stage in its development project t...
January 07, 2022 | News
Curia Unveils Comprehensive mRNA Solution
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today unveiled its messenger RNA (mRNA) solution, which incl...
December 27, 2021 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
